Synovate Healthcare Names US Custom Research Head

Synovate Healthcare has appointed Greg Chu as Head of US Custom Research, based in the Princeton office and responsible for consolidating the firm's position in North America.

He joins from Novartis where he was VP Business Analysis. Prior to this he was Senior Director Market Research at Forest Laboratories in New York, and Executive Director of Business Information and Research at pharmaceutical company MSD. He has also worked as Product Manager for MSD in France.

Commented MD Europe & Asia, Bob Douglas: 'The US is Synovate Healthcare's single biggest market and I have no doubt that Greg's talent and experience will make a significant contribution to driving our future business success.'

Synovate Healthcare employs more than 500 healthcare market research professionals across Europe, US, Asia Pacific and Japan. Earlier this week, the firm announced its acquisition of US research firm Oncology Inc (www.mrweb.com/drno/news7770.htm). Home page: www.synovate.com/healthcare.